<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1492</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7494256</PubmedId>
            <Abstract>The human CD4+ T-cell repertoire of responses to hemagglutinin (HA) of influenza virus A/Beijing/32/92 was examined 3 to 6 months after natural infection by using a panel of 16-mer peptides overlapping by 11 residues. Short-term CD4+ T-cell lines were derived by using full-length HAs of virus A/Beijing/32/92 from 12 unrelated, major histocompatibility complex (MHC) class I and II haplotyped adults with a history of influenza in November and December 1993 and from 6 adults with no history of influenza during the preceding 4 years but who responded to HA. In contrast to recent murine studies, the human CD4+ T-cell repertoire of responses was dominated by the recognition of highly conserved epitopes. The HA2 subunit, widely regarded as nonimmunogenic, induced strong responses in every donor. This resulted in functional cross-reactivity among influenza A viruses. Our study included one pair of unrelated donors expressing identical HLA DRB1 and DQB1 alleles and two pairs of donors sharing low-resolution MHC class II types. These pairs responded to identical peptides; furthermore, clearly identifiable patterns of response were seen in donors sharing single class II haplotypes, irrespective of the presence of other alleles and exposure history. Two conserved regions which induced responses in 17 of 18 donors were identified (residues 295 to 328 and 407 to 442). Possible implications for cross-reactive T-cell vaccines are discussed.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>7497-506</ArticlePages>
            <ArticleTitle>Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Gelder</LastName>
                    <ForeName>C M</ForeName>
                </Author>
                <Author>
                    <LastName>Welsh</LastName>
                    <ForeName>K I</ForeName>
                </Author>
                <Author>
                    <LastName>Faith</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Lamb</LastName>
                    <ForeName>J R</ForeName>
                </Author>
                <Author>
                    <LastName>Askonas</LastName>
                    <ForeName>B A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Biology, Imperial College of Science, Technology and Medicine, London, England.</Affiliations>
            <ArticleChemicalList>HLA-DR Antigens;HLA-DRB1 Chains;Hemagglutinin Glycoproteins, Influenza Virus;Hemagglutinins, Viral;Macromolecular Substances;Peptide Fragments</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adult; Alleles; Amino Acid Sequence; CD4-Positive T-Lymphocytes(immunology; virology); Cell Line; Conserved Sequence; Female; Follow-Up Studies; HLA-DR Antigens(genetics; immunology); HLA-DRB1 Chains; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins, Viral(chemistry; immunology); Histocompatibility Testing; Humans; Influenza A virus(immunology); Influenza, Human(genetics; immunology); Lymphocyte Activation; Macromolecular Substances; Major Histocompatibility Complex; Male; Middle Aged; Molecular Sequence Data; Peptide Fragments(chemistry); Time Factors</ArticleMeshHeadingsList>
            <Journal>
                <Volume>69</Volume>
                <Issue>12</Issue>
                <Title>Journal of virology</Title>
                <Issn>1098-5514</Issn>
                <MedlineTa>J Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HA 1-35</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QKLPGNDNSTATLCLGHHAVPNGTLVKTITNDQIE</LinearSequence>
                        <StartingPosition>17</StartingPosition>
                        <EndingPosition>51</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>51221</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>35</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 1-35 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 1-35 sequence corresponds to amino acids 17-51 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004879</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 1-35</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QKLPGNDNSTATLCLGHHAVPNGTLVKTITNDQIE</LinearSequence>
                                        <StartingPosition>17</StartingPosition>
                                        <EndingPosition>51</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>9</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 1-35 for reactivity. T cells from 9 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 25-59</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVKTITNDQIEVTNATELVQSSSTGRICDSPHRIL</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>75</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>40430</EpitopeId>
                <ReferenceStartingPosition>25</ReferenceStartingPosition>
                <ReferenceEndingPosition>59</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 25-59 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 25-59 sequence corresponds to amino acids 41-75 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004880</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 25-59</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVKTITNDQIEVTNATELVQSSSTGRICDSPHRIL</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>75</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>10</NumberOfSubjectsResponded>
                            <ResponseFrequency>55.6</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 25-59 for reactivity. T cells from 10 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 49-82</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GRICDSPHRILDGKNCTLIDALLGDPHCDGFQCK</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC133</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>22070</EpitopeId>
                <ReferenceStartingPosition>49</ReferenceStartingPosition>
                <ReferenceEndingPosition>82</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 49-82 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The sequence is said to be derived from Influenza A virus (A/Beijing/32/92(H3N2)) sequence but the sequence found in that strain database is GRICDSPHRILDGKNCTLIDALLGDPHCDGFQNK, where residue at position 81 is an N instead of a C. An internal source is provided to account for the difference in amino acid sequence between the reported epitope and the existing database sequences for HA protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004881</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <IedbAccession>SRC133</IedbAccession>
                                            </Molecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Internal Identifier-no external match available</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 49-82</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GRICDSPHRILDGKNCTLIDALLGDPHCDGFQCK</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC133</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11320</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>11.1</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 49-82 for reactivity. T cells from 2 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 72-107</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GDPHCDGFQCKEWDLFVERSKAYSNCYPYDVPDYAS</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC133</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>19072</EpitopeId>
                <ReferenceStartingPosition>72</ReferenceStartingPosition>
                <ReferenceEndingPosition>107</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 72-107 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The sequence is said to be derived from Influenza A virus (A/Beijing/32/92(H3N2)) sequence but the sequence found in that strain database is GDPHCDGFQNKEWDLFVERSKAYSNCYPYDVPDYAS, where residue at position 81 is an N instead of a C. An internal source is provided to account for the difference in amino acid sequence between the reported epitope and the existing database sequences for HA protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004895</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <IedbAccession>SRC133</IedbAccession>
                                            </Molecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Internal Identifier-no external match available</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 72-107</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDPHCDGFQCKEWDLFVERSKAYSNCYPYDVPDYAS</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC133</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11320</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>7</NumberOfSubjectsResponded>
                            <ResponseFrequency>38.9</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 72-107 for reactivity. T cells from 7 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 97-128</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CYPYDVPDYASLRSLVASSGTLEFINEDFNWT</LinearSequence>
                        <StartingPosition>113</StartingPosition>
                        <EndingPosition>144</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>7431</EpitopeId>
                <ReferenceStartingPosition>97</ReferenceStartingPosition>
                <ReferenceEndingPosition>128</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 97-128 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. The HA 97-128 sequence corresponds to amino acids 113-144 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004896</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 97-128</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CYPYDVPDYASLRSLVASSGTLEFINEDFNWT</LinearSequence>
                                        <StartingPosition>113</StartingPosition>
                                        <EndingPosition>144</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>14</NumberOfSubjectsResponded>
                            <ResponseFrequency>77.8</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 97-128 for reactivity. T cells from 14 donors responded to the pool. T cells from one individual donor responded to 3 individual peptides within the pool (HA 97-112, HA 100-115, and HA 105-120), but not to the other two peptides within the pool (HA 110-125 and HA 113-128).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 118-147</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LEFINEDFNWTGVAQDGGSYACKRGSVNSF</LinearSequence>
                        <StartingPosition>134</StartingPosition>
                        <EndingPosition>163</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>35462</EpitopeId>
                <ReferenceStartingPosition>118</ReferenceStartingPosition>
                <ReferenceEndingPosition>147</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 118-147 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. The HA 118-147 sequence corresponds to amino acids 134-163 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004905</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 118-147</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LEFINEDFNWTGVAQDGGSYACKRGSVNSF</LinearSequence>
                                        <StartingPosition>134</StartingPosition>
                                        <EndingPosition>163</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>22.2</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 118-147 for reactivity. T cells from 4 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 137-171</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YACKRGSVNSFFSRLNWLHKSEYKYPALNVTMPNN</LinearSequence>
                        <StartingPosition>153</StartingPosition>
                        <EndingPosition>187</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>73337</EpitopeId>
                <ReferenceStartingPosition>137</ReferenceStartingPosition>
                <ReferenceEndingPosition>171</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 137-171 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 137-171 sequence corresponds to amino acids 153-187 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004908</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 137-171</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YACKRGSVNSFFSRLNWLHKSEYKYPALNVTMPNN</LinearSequence>
                                        <StartingPosition>153</StartingPosition>
                                        <EndingPosition>187</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>22.2</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 137-171 for reactivity. T cells from 4 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 161-193</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YPALNVTMPNNGKFDKLYIWGVHHPSTDRDQTS</LinearSequence>
                        <StartingPosition>177</StartingPosition>
                        <EndingPosition>209</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>75259</EpitopeId>
                <ReferenceStartingPosition>161</ReferenceStartingPosition>
                <ReferenceEndingPosition>193</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 161-193 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 161-193 sequence corresponds to amino acids 177-209 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004974</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 161-193</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YPALNVTMPNNGKFDKLYIWGVHHPSTDRDQTS</LinearSequence>
                                        <StartingPosition>177</StartingPosition>
                                        <EndingPosition>209</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>7</NumberOfSubjectsResponded>
                            <ResponseFrequency>38.9</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 161-193 for reactivity. T cells from 7 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 183-217</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HHPSTDRDQTSLYVRASGRVTVSTKRSQQTVTPNI</LinearSequence>
                        <StartingPosition>199</StartingPosition>
                        <EndingPosition>233</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>24011</EpitopeId>
                <ReferenceStartingPosition>183</ReferenceStartingPosition>
                <ReferenceEndingPosition>217</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 183-217 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. The HA 183-217 sequence corresponds to amino acids 199-233 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004987</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 183-217</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HHPSTDRDQTSLYVRASGRVTVSTKRSQQTVTPNI</LinearSequence>
                                        <StartingPosition>199</StartingPosition>
                                        <EndingPosition>233</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>10</NumberOfSubjectsResponded>
                            <ResponseFrequency>55.6</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 183-217 for reactivity. T cells from 10 donors responded to the pool.  T cells from one individual donor responded to 2 individual peptides within the pool (HA 192-207 and HA 198-213), but not to the other 3 peptides within the pool (HA 183-198, HA 188-203 and HA 202-217).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 208-243</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RSQQTVTPNIGSRPWVRGQSSRISIYWTIVKPGDIL</LinearSequence>
                        <StartingPosition>224</StartingPosition>
                        <EndingPosition>259</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>55934</EpitopeId>
                <ReferenceStartingPosition>208</ReferenceStartingPosition>
                <ReferenceEndingPosition>243</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 208-243 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. The HA 208-243 sequence corresponds to amino acids 224-259 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004990</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 208-243</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RSQQTVTPNIGSRPWVRGQSSRISIYWTIVKPGDIL</LinearSequence>
                                        <StartingPosition>224</StartingPosition>
                                        <EndingPosition>259</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 208-243 for reactivity. T cells from 6 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 232-262</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IYWTIVKPGDILLINSTGNLIAPRGYFKIRN</LinearSequence>
                        <StartingPosition>248</StartingPosition>
                        <EndingPosition>278</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>29728</EpitopeId>
                <ReferenceStartingPosition>232</ReferenceStartingPosition>
                <ReferenceEndingPosition>262</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 232-262 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 232-262 sequence corresponds to amino acids 248-278 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004993</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 232-262</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYWTIVKPGDILLINSTGNLIAPRGYFKIRN</LinearSequence>
                                        <StartingPosition>248</StartingPosition>
                                        <EndingPosition>278</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 232-262 for reactivity. T cells from 6 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 252-283</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IAPRGYFKIRNGKSSIMRSDAPIGTCSSECIT</LinearSequence>
                        <StartingPosition>268</StartingPosition>
                        <EndingPosition>299</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>25382</EpitopeId>
                <ReferenceStartingPosition>252</ReferenceStartingPosition>
                <ReferenceEndingPosition>283</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 252-283 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 252-283 sequence corresponds to amino acids 268-299 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004995</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 252-283</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IAPRGYFKIRNGKSSIMRSDAPIGTCSSECIT</LinearSequence>
                                        <StartingPosition>268</StartingPosition>
                                        <EndingPosition>299</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>16.7</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 252-283 for reactivity. T cells from 3 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 273-305</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PIGTCSSECITPNGSIPNDKPFQNVNRITYGAC</LinearSequence>
                        <StartingPosition>289</StartingPosition>
                        <EndingPosition>321</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>47909</EpitopeId>
                <ReferenceStartingPosition>273</ReferenceStartingPosition>
                <ReferenceEndingPosition>305</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 273-305 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. The HA 273-305 sequence corresponds to amino acids 289-321 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004996</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 273-305</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PIGTCSSECITPNGSIPNDKPFQNVNRITYGAC</LinearSequence>
                                        <StartingPosition>289</StartingPosition>
                                        <EndingPosition>321</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>7</NumberOfSubjectsResponded>
                            <ResponseFrequency>38.9</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 273-305 for reactivity. T cells from 7 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 295-328</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QNVNRITYGACPRYVKQNTLKLATGMRNVPEKQT</LinearSequence>
                        <StartingPosition>311</StartingPosition>
                        <EndingPosition>344</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>51780</EpitopeId>
                <ReferenceStartingPosition>295</ReferenceStartingPosition>
                <ReferenceEndingPosition>328</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 295-328 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. The HA 295-328 sequence corresponds to amino acids 311-344 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004997</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 295-328</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QNVNRITYGACPRYVKQNTLKLATGMRNVPEKQT</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>344</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>18</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 295-328 for reactivity. T cells from all 18 donors responded to the pool. T cells from one individual donor responded to 2 individual peptides within the pool (HA 303-318 and HA 308-323), but not to the other 3 peptides within the pool (HA 295-310, HA 300-315 and HA 313-328).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 317-348</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ATGMRNVPEKQTRGIFGAIAGFIENGWEGMVD</LinearSequence>
                        <StartingPosition>317</StartingPosition>
                        <EndingPosition>348</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>4974</EpitopeId>
                <ReferenceStartingPosition>317</ReferenceStartingPosition>
                <ReferenceEndingPosition>348</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 317-348 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1004998</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 317-348</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ATGMRNVPEKQTRGIFGAIAGFIENGWEGMVD</LinearSequence>
                                        <StartingPosition>317</StartingPosition>
                                        <EndingPosition>348</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>22.2</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 317-348 for reactivity. T cells from 4 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 336-369</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AGFIENGWEGMVDGWYGFRHQNSEGTGQAADLKS</LinearSequence>
                        <StartingPosition>336</StartingPosition>
                        <EndingPosition>369</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>1507</EpitopeId>
                <ReferenceStartingPosition>336</ReferenceStartingPosition>
                <ReferenceEndingPosition>369</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 336-369 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005000</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influena A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 336-369</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AGFIENGWEGMVDGWYGFRHQNSEGTGQAADLKS</LinearSequence>
                                        <StartingPosition>336</StartingPosition>
                                        <EndingPosition>369</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>11.1</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 336-369 for reactivity. T cells from 2 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 357-393</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NSEGTGQAADLKSTQAAIDQINGKLNRLIEKTNEKFH</LinearSequence>
                        <StartingPosition>357</StartingPosition>
                        <EndingPosition>393</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>45793</EpitopeId>
                <ReferenceStartingPosition>357</ReferenceStartingPosition>
                <ReferenceEndingPosition>393</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 357-393 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005003</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 357-393</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NSEGTGQAADLKSTQAAIDQINGKLNRLIEKTNEKFH</LinearSequence>
                                        <StartingPosition>357</StartingPosition>
                                        <EndingPosition>393</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>10</NumberOfSubjectsResponded>
                            <ResponseFrequency>55.6</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 357-393 for reactivity. T cells from 10 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 384-418</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LIEKTNEKFHQIEKEFSEVEGRIQDLEKYVEDTKI</LinearSequence>
                        <StartingPosition>384</StartingPosition>
                        <EndingPosition>418</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>36498</EpitopeId>
                <ReferenceStartingPosition>384</ReferenceStartingPosition>
                <ReferenceEndingPosition>418</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 384-418 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005004</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 384-418</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LIEKTNEKFHQIEKEFSEVEGRIQDLEKYVEDTKI</LinearSequence>
                                        <StartingPosition>384</StartingPosition>
                                        <EndingPosition>418</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>13</NumberOfSubjectsResponded>
                            <ResponseFrequency>72.2</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 384-418 for reactivity. T cells from 13 donors responded to the pool. T cells from one individual donor responded to 1 individual peptide within the pool (HA 388-403), but not to the other 4 peptides within the pool (HA 384-399, HA 393-408, HA 398-413 and HA 403-418).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 407-442</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS</LinearSequence>
                        <StartingPosition>407</StartingPosition>
                        <EndingPosition>442</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>50489</EpitopeId>
                <ReferenceStartingPosition>407</ReferenceStartingPosition>
                <ReferenceEndingPosition>442</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 407-442 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005006</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 407-442</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS</LinearSequence>
                                        <StartingPosition>407</StartingPosition>
                                        <EndingPosition>442</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>17</NumberOfSubjectsResponded>
                            <ResponseFrequency>94.4</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 407-442 for reactivity. T cells from 17 of the 18 donors responded to the pool. T cells from one individual donor responded to 2 of the individual peptides within the pool (HA 407-422 and HA 422-437), but not to the other 3 peptides within the pool (HA 412-427, HA 417-432 and HA 427-442).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 432-468</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ENQHTIDLTDSEMNKLFEKTRKQLRENAEDMGNGCF</LinearSequence>
                        <StartingPosition>432</StartingPosition>
                        <EndingPosition>467</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>13575</EpitopeId>
                <ReferenceStartingPosition>432</ReferenceStartingPosition>
                <ReferenceEndingPosition>468</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 432-468 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005008</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 432-468</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ENQHTIDLTDSEMNKLFEKTRKQLRENAEDMGNGCF</LinearSequence>
                                        <StartingPosition>432</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>27.8</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 432-468 for reactivity. T cells from 5 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 456-488</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RENAEDMGNGCFKIYHKCDNACIGSIRNGTYDH</LinearSequence>
                        <StartingPosition>456</StartingPosition>
                        <EndingPosition>488</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>53588</EpitopeId>
                <ReferenceStartingPosition>456</ReferenceStartingPosition>
                <ReferenceEndingPosition>488</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 456-488 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005009</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 456-488</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RENAEDMGNGCFKIYHKCDNACIGSIRNGTYDH</LinearSequence>
                                        <StartingPosition>456</StartingPosition>
                                        <EndingPosition>488</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>13</NumberOfSubjectsResponded>
                            <ResponseFrequency>72.2</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 456-488 for reactivity. T cells from 13 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 478-513</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IGSIRNGTYDHDVYRDEALNNRFQIKGVELKSGYKD</LinearSequence>
                        <StartingPosition>478</StartingPosition>
                        <EndingPosition>513</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>26322</EpitopeId>
                <ReferenceStartingPosition>478</ReferenceStartingPosition>
                <ReferenceEndingPosition>513</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 478-513 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005010</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 478-513</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IGSIRNGTYDHDVYRDEALNNRFQIKGVELKSGYKD</LinearSequence>
                                        <StartingPosition>478</StartingPosition>
                                        <EndingPosition>513</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>5.6</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 478-513 for reactivity. T cells from 1 out of 18 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 503-536</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGVELKSGYKDWILWISFAISCFLLCVVLLGFIM</LinearSequence>
                        <StartingPosition>503</StartingPosition>
                        <EndingPosition>536</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>31082</EpitopeId>
                <ReferenceStartingPosition>503</ReferenceStartingPosition>
                <ReferenceEndingPosition>536</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 503-536 epitopic region was mapped with a pool of five 16-mer peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005011</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 503-536</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGVELKSGYKDWILWISFAISCFLLCVVLLGFIM</LinearSequence>
                                        <StartingPosition>503</StartingPosition>
                                        <EndingPosition>536</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>11</NumberOfSubjectsResponded>
                            <ResponseFrequency>61.1</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 503-536 for reactivity. T cells from 11 out of 18 donors responded to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 526-550</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLCVVLLGFIMWACQKGNIRCNICI</LinearSequence>
                        <StartingPosition>526</StartingPosition>
                        <EndingPosition>550</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>37138</EpitopeId>
                <ReferenceStartingPosition>526</ReferenceStartingPosition>
                <ReferenceEndingPosition>550</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 526-550 epitopic region was mapped with a pool of three overlapping peptides encompassing this region, but no further fine epitope mapping was done. Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2, 3 and 4</LocationOfData>
                        <TCellId>1005012</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 526-550</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLCVVLLGFIMWACQKGNIRCNICI</LinearSequence>
                                        <StartingPosition>526</StartingPosition>
                                        <EndingPosition>550</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>5.6</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). The CD4+ T cell lines were derived from 18 different donors. Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. All donors made a polyclonal response to HA, and a variety of MHC haplotypes were present within the group of 18 donors. The CD4+ T cell lines were stimulated with HA for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 526-550 for reactivity. T cells from 1 out of 18 donors responded weakly to the pool, but individual peptides from the pool were not tested to map fine specificity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 97-112</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CYPYDVPDYASLRSLV</LinearSequence>
                        <StartingPosition>113</StartingPosition>
                        <EndingPosition>128</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>7429</EpitopeId>
                <ReferenceStartingPosition>97</ReferenceStartingPosition>
                <ReferenceEndingPosition>112</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 97-112 sequence corresponds to amino acids 113-128 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005051</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 97-112</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CYPYDVPDYASLRSLV</LinearSequence>
                                        <StartingPosition>113</StartingPosition>
                                        <EndingPosition>128</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 97-128 for reactivity. T cells from the individual donor responded to 3 individual peptides within the pool (HA 97-112, HA 100-115, and HA 105-120), but not to the other two peptides within the pool (HA 110-125 and HA 113-128).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 100-115</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YDVPDYASLRSLVASS</LinearSequence>
                        <StartingPosition>116</StartingPosition>
                        <EndingPosition>131</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>73603</EpitopeId>
                <ReferenceStartingPosition>100</ReferenceStartingPosition>
                <ReferenceEndingPosition>115</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 100-115 sequence corresponds to amino acids 116-131 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005054</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 100-115</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YDVPDYASLRSLVASS</LinearSequence>
                                        <StartingPosition>116</StartingPosition>
                                        <EndingPosition>131</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 97-128 for reactivity. T cells from the individual donor responded to 3 individual peptides within the pool (HA 97-112, HA 100-115, and HA 105-120), but not to the other two peptides within the pool (HA 110-125 and HA 113-128).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 105-120</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YASLRSLVASSGTLEF</LinearSequence>
                        <StartingPosition>121</StartingPosition>
                        <EndingPosition>136</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>73443</EpitopeId>
                <ReferenceStartingPosition>105</ReferenceStartingPosition>
                <ReferenceEndingPosition>120</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 105-120 sequence corresponds to amino acids 121-136 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005055</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 105-120</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YASLRSLVASSGTLEF</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>136</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 97-128 for reactivity. T cells from the individual donor responded to 3 individual peptides within the pool (HA 97-112, HA 100-115, and HA 105-120), but not to the other two peptides within the pool (HA 110-125 and HA 113-128).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 110-125</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLVASSGTLEFINEDF</LinearSequence>
                        <StartingPosition>126</StartingPosition>
                        <EndingPosition>141</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>59532</EpitopeId>
                <ReferenceStartingPosition>110</ReferenceStartingPosition>
                <ReferenceEndingPosition>125</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 110-125 sequence corresponds to amino acids 126-141 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005056</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 110-125</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLVASSGTLEFINEDF</LinearSequence>
                                        <StartingPosition>126</StartingPosition>
                                        <EndingPosition>141</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 97-128 for reactivity. T cells from the individual donor responded to 3 individual peptides within the pool (HA 97-112, HA 100-115, and HA 105-120), but not to the other two peptides within the pool (HA 110-125 and HA 113-128).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 113-128</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASSGTLEFINEDFNWT</LinearSequence>
                        <StartingPosition>129</StartingPosition>
                        <EndingPosition>144</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>4772</EpitopeId>
                <ReferenceStartingPosition>113</ReferenceStartingPosition>
                <ReferenceEndingPosition>128</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 113-128 sequence corresponds to amino acids 129-144 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005057</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 113-128</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASSGTLEFINEDFNWT</LinearSequence>
                                        <StartingPosition>129</StartingPosition>
                                        <EndingPosition>144</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 97-128 for reactivity. T cells from the individual donor responded to 3 individual peptides within the pool (HA 97-112, HA 100-115, and HA 105-120), but not to the other two peptides within the pool (HA 110-125 and HA 113-128).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 183-198</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HHPSTDRDQTSLYVRA</LinearSequence>
                        <StartingPosition>199</StartingPosition>
                        <EndingPosition>214</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>24010</EpitopeId>
                <ReferenceStartingPosition>183</ReferenceStartingPosition>
                <ReferenceEndingPosition>198</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 183-198 sequence corresponds to amino acids 199-214 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005059</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 183-198</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HHPSTDRDQTSLYVRA</LinearSequence>
                                        <StartingPosition>199</StartingPosition>
                                        <EndingPosition>214</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 183-213 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 192-207 and HA 198-213), but not to the other 3 peptides within the pool (HA 183-198, HA 188-203 and HA 202-217).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 188-203</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DRDQTSLYVRASGRVT</LinearSequence>
                        <StartingPosition>204</StartingPosition>
                        <EndingPosition>219</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>9959</EpitopeId>
                <ReferenceStartingPosition>188</ReferenceStartingPosition>
                <ReferenceEndingPosition>203</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 188-203 sequence corresponds to amino acids 204-219 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005061</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 188-203</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DRDQTSLYVRASGRVT</LinearSequence>
                                        <StartingPosition>204</StartingPosition>
                                        <EndingPosition>219</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 183-213 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 192-207 and HA 198-213), but not to the other 3 peptides within the pool (HA 183-198, HA 188-203 and HA 202-217).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 192-207</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TSLYVRASGRVTVSTK</LinearSequence>
                        <StartingPosition>208</StartingPosition>
                        <EndingPosition>223</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>66325</EpitopeId>
                <ReferenceStartingPosition>192</ReferenceStartingPosition>
                <ReferenceEndingPosition>207</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 192-207 sequence corresponds to amino acids 208-223 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005100</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 192-207</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSLYVRASGRVTVSTK</LinearSequence>
                                        <StartingPosition>208</StartingPosition>
                                        <EndingPosition>223</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). Two donors were screened for reactivity against the HA 192-207 peptide. The proliferative response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005062</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 192-207</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSLYVRASGRVTVSTK</LinearSequence>
                                        <StartingPosition>208</StartingPosition>
                                        <EndingPosition>223</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 183-213 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 192-207 and HA 198-213), but not to the other 3 peptides within the pool (HA 183-198, HA 188-203 and HA 202-217).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 198-213</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASGRVTVSTKRSQQTV</LinearSequence>
                        <StartingPosition>214</StartingPosition>
                        <EndingPosition>229</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>4433</EpitopeId>
                <ReferenceStartingPosition>198</ReferenceStartingPosition>
                <ReferenceEndingPosition>213</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 198-213 sequence corresponds to amino acids 214-229 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005063</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 198-213</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASGRVTVSTKRSQQTV</LinearSequence>
                                        <StartingPosition>214</StartingPosition>
                                        <EndingPosition>229</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 183-213 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 192-207 and HA 198-213), but not to the other 3 peptides within the pool (HA 183-198, HA 188-203 and HA 202-217).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 202-217</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VTVSTKRSQQTVTPNI</LinearSequence>
                        <StartingPosition>218</StartingPosition>
                        <EndingPosition>233</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>71561</EpitopeId>
                <ReferenceStartingPosition>202</ReferenceStartingPosition>
                <ReferenceEndingPosition>217</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 202-217 sequence corresponds to amino acids 218-233 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005065</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 202-217</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VTVSTKRSQQTVTPNI</LinearSequence>
                                        <StartingPosition>218</StartingPosition>
                                        <EndingPosition>233</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 183-217 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 192-207 and HA 198-213), but not to the other 3 peptides within the pool (HA 183-198, HA 188-203 and HA 202-217).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 295-310</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QNVNRITYGACPRYVK</LinearSequence>
                        <StartingPosition>311</StartingPosition>
                        <EndingPosition>326</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>51779</EpitopeId>
                <ReferenceStartingPosition>295</ReferenceStartingPosition>
                <ReferenceEndingPosition>310</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 295-310 sequence corresponds to amino acids 311-326 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005066</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 295-310</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QNVNRITYGACPRYVK</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>326</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 295-328 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 303-318 and HA 308-323), but not to the other 3 peptides within the pool (HA 295-310, HA 300-315 and HA 313-328).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 300-315</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ITYGACPRYVKQNTLK</LinearSequence>
                        <StartingPosition>316</StartingPosition>
                        <EndingPosition>331</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>29161</EpitopeId>
                <ReferenceStartingPosition>300</ReferenceStartingPosition>
                <ReferenceEndingPosition>315</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 300-315 sequence corresponds to amino acids 316-331 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005067</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 300-315</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ITYGACPRYVKQNTLK</LinearSequence>
                                        <StartingPosition>316</StartingPosition>
                                        <EndingPosition>331</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 295-328 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 303-318 and HA 308-323), but not to the other 3 peptides within the pool (HA 295-310, HA 300-315 and HA 313-328).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 303-318</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GACPRYVKQNTLKLAT</LinearSequence>
                        <StartingPosition>319</StartingPosition>
                        <EndingPosition>334</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>18545</EpitopeId>
                <ReferenceStartingPosition>303</ReferenceStartingPosition>
                <ReferenceEndingPosition>318</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 303-318 sequence corresponds to amino acids 319-334 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005068</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 303-318</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GACPRYVKQNTLKLAT</LinearSequence>
                                        <StartingPosition>319</StartingPosition>
                                        <EndingPosition>334</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 295-328 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 303-318 and HA 308-323), but not to the other 3 peptides within the pool (HA 295-310, HA 300-315 and HA 313-328).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 308-323</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YVKQNTLKLATGMRNV</LinearSequence>
                        <StartingPosition>324</StartingPosition>
                        <EndingPosition>339</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>76320</EpitopeId>
                <ReferenceStartingPosition>308</ReferenceStartingPosition>
                <ReferenceEndingPosition>323</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 308-323 sequence corresponds to amino acids 324-339 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005069</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 308-323</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YVKQNTLKLATGMRNV</LinearSequence>
                                        <StartingPosition>324</StartingPosition>
                                        <EndingPosition>339</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 295-328 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 303-318 and HA 308-323), but not to the other 3 peptides within the pool (HA 295-310, HA 300-315 and HA 313-328).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 313-328</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TLKLATGMRNVPEKQT</LinearSequence>
                        <StartingPosition>329</StartingPosition>
                        <EndingPosition>344</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>64879</EpitopeId>
                <ReferenceStartingPosition>313</ReferenceStartingPosition>
                <ReferenceEndingPosition>328</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 313-328 sequence corresponds to amino acids 329-344 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005071</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 313-328</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TLKLATGMRNVPEKQT</LinearSequence>
                                        <StartingPosition>329</StartingPosition>
                                        <EndingPosition>344</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 295-328 for reactivity. T cells from the individual donor responded to 2 individual peptides within the pool (HA 303-318 and HA 308-323), but not to the other 3 peptides within the pool (HA 295-310, HA 300-315 and HA 313-328).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 384-399</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LIEKTNEKFHQIEKEF</LinearSequence>
                        <StartingPosition>384</StartingPosition>
                        <EndingPosition>399</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>36497</EpitopeId>
                <ReferenceStartingPosition>384</ReferenceStartingPosition>
                <ReferenceEndingPosition>399</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005073</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 384-399</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LIEKTNEKFHQIEKEF</LinearSequence>
                                        <StartingPosition>384</StartingPosition>
                                        <EndingPosition>399</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 384-418 for reactivity. T cells from the individual donor responded to 1 individual peptide within the pool (HA 388-403), but not to the other 4 peptides within the pool (HA 384-399, HA 393-408, HA 398-413 and HA 403-418).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 388-403</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TNEKFHQIEKEFSEVE</LinearSequence>
                        <StartingPosition>388</StartingPosition>
                        <EndingPosition>403</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>65310</EpitopeId>
                <ReferenceStartingPosition>388</ReferenceStartingPosition>
                <ReferenceEndingPosition>403</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005074</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 388-403</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TNEKFHQIEKEFSEVE</LinearSequence>
                                        <StartingPosition>388</StartingPosition>
                                        <EndingPosition>403</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 384-418 for reactivity. T cells from the individual donor responded to 1 individual peptide within the pool (HA 388-403), but not to the other 4 peptides within the pool (HA 384-399, HA 393-408, HA 398-413 and HA 403-418).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 393-408</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HQIEKEFSEVEGRIQD</LinearSequence>
                        <StartingPosition>393</StartingPosition>
                        <EndingPosition>408</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>24579</EpitopeId>
                <ReferenceStartingPosition>393</ReferenceStartingPosition>
                <ReferenceEndingPosition>408</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005076</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 393-408</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HQIEKEFSEVEGRIQD</LinearSequence>
                                        <StartingPosition>393</StartingPosition>
                                        <EndingPosition>408</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 384-418 for reactivity. T cells from the individual donor responded to 1 individual peptide within the pool (HA 388-403), but not to the other 4 peptides within the pool (HA 384-399, HA 393-408, HA 398-413 and HA 403-418).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 398-413</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EFSEVEGRIQDLEKYV</LinearSequence>
                        <StartingPosition>398</StartingPosition>
                        <EndingPosition>413</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>12070</EpitopeId>
                <ReferenceStartingPosition>398</ReferenceStartingPosition>
                <ReferenceEndingPosition>413</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005077</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 398-413</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EFSEVEGRIQDLEKYV</LinearSequence>
                                        <StartingPosition>398</StartingPosition>
                                        <EndingPosition>413</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 384-418 for reactivity. T cells from the individual donor responded to 1 individual peptide within the pool (HA 388-403), but not to the other 4 peptides within the pool (HA 384-399, HA 393-408, HA 398-413 and HA 403-418).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 403-418</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EGRIQDLEKYVEDTKI</LinearSequence>
                        <StartingPosition>403</StartingPosition>
                        <EndingPosition>418</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>12262</EpitopeId>
                <ReferenceStartingPosition>403</ReferenceStartingPosition>
                <ReferenceEndingPosition>418</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005083</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 403-418</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EGRIQDLEKYVEDTKI</LinearSequence>
                                        <StartingPosition>403</StartingPosition>
                                        <EndingPosition>418</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 384-418 for reactivity. T cells from the individual donor responded to 1 individual peptide within the pool (HA 388-403), but not to the other 4 peptides within the pool (HA 384-399, HA 393-408, HA 398-413 and HA 403-418).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 407-422</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QDLEKYVEDTKIDLWS</LinearSequence>
                        <StartingPosition>407</StartingPosition>
                        <EndingPosition>422</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>50488</EpitopeId>
                <ReferenceStartingPosition>407</ReferenceStartingPosition>
                <ReferenceEndingPosition>422</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005084</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 407-422</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QDLEKYVEDTKIDLWS</LinearSequence>
                                        <StartingPosition>407</StartingPosition>
                                        <EndingPosition>422</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 407-442 for reactivity. T cells from the individual donor responded to 2 of the individual peptides within the pool (HA 407-422 and HA 422-437), but not to the other 3 peptides within the pool (HA 412-427, HA 417-432 and HA 427-442).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 412-427</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YVEDTKIDLWSYNAEL</LinearSequence>
                        <StartingPosition>412</StartingPosition>
                        <EndingPosition>427</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>76259</EpitopeId>
                <ReferenceStartingPosition>412</ReferenceStartingPosition>
                <ReferenceEndingPosition>427</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005085</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 412-427</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YVEDTKIDLWSYNAEL</LinearSequence>
                                        <StartingPosition>412</StartingPosition>
                                        <EndingPosition>427</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 407-442 for reactivity. T cells from the individual donor responded to 2 of the individual peptides within the pool (HA 407-422 and HA 422-437), but not to the other 3 peptides within the pool (HA 412-427, HA 417-432 and HA 427-442).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 417-432</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KIDLWSYNAELLVALE</LinearSequence>
                        <StartingPosition>417</StartingPosition>
                        <EndingPosition>432</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>31200</EpitopeId>
                <ReferenceStartingPosition>417</ReferenceStartingPosition>
                <ReferenceEndingPosition>432</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005086</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 417-432</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KIDLWSYNAELLVALE</LinearSequence>
                                        <StartingPosition>417</StartingPosition>
                                        <EndingPosition>432</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 407-442 for reactivity. T cells from the individual donor responded to 2 of the individual peptides within the pool (HA 407-422 and HA 422-437), but not to the other 3 peptides within the pool (HA 412-427, HA 417-432 and HA 427-442).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 422-437</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SYNAELLVALENQHTI</LinearSequence>
                        <StartingPosition>422</StartingPosition>
                        <EndingPosition>437</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>62654</EpitopeId>
                <ReferenceStartingPosition>422</ReferenceStartingPosition>
                <ReferenceEndingPosition>437</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005087</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 422-437</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYNAELLVALENQHTI</LinearSequence>
                                        <StartingPosition>422</StartingPosition>
                                        <EndingPosition>437</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 407-442 for reactivity. T cells from the individual donor responded to 2 of the individual peptides within the pool (HA 407-422 and HA 422-437), but not to the other 3 peptides within the pool (HA 412-427, HA 417-432 and HA 427-442).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 427-442</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLVALENQHTIDLTDS</LinearSequence>
                        <StartingPosition>427</StartingPosition>
                        <EndingPosition>442</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>37883</EpitopeId>
                <ReferenceStartingPosition>427</ReferenceStartingPosition>
                <ReferenceEndingPosition>442</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2d</LocationOfData>
                        <TCellId>1005088</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>52</MhcAlleleId>
                                    <MhcAlleleId>330</MhcAlleleId>
                                    <MhcAlleleId>357</MhcAlleleId>
                                    <MhcAlleleId>317</MhcAlleleId>
                                    <MhcAlleleId>321</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 427-442</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLVALENQHTIDLTDS</LinearSequence>
                                        <StartingPosition>427</StartingPosition>
                                        <EndingPosition>442</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CD4+ T cell lines from an individual donor were stimulated with HA protein for 2-3 weeks and then used in a proliferation assay to screen a pool of 16-mer peptides (5 peptides) encompassing HA 407-442 for reactivity. T cells from the individual donor responded to 2 of the individual peptides within the pool (HA 407-422 and HA 422-437), but not to the other 3 peptides within the pool (HA 412-427, HA 417-432 and HA 427-442).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 20-40</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VPNGTLVKTITNDQIEVTNAT</LinearSequence>
                        <StartingPosition>36</StartingPosition>
                        <EndingPosition>56</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>70381</EpitopeId>
                <ReferenceStartingPosition>20</ReferenceStartingPosition>
                <ReferenceEndingPosition>40</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 20-40 sequence corresponds to amino acids 36-56 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005098</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 20-40</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VPNGTLVKTITNDQIEVTNAT</LinearSequence>
                                        <StartingPosition>36</StartingPosition>
                                        <EndingPosition>56</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/93). Two donors were screened for reactivity against the  HA 20-40 region by pooling two overlapping peptides (HA 20-35 and HA 25-40). The response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 97-115</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CYPYDVPDYASLRSLVASS</LinearSequence>
                        <StartingPosition>113</StartingPosition>
                        <EndingPosition>131</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>7430</EpitopeId>
                <ReferenceStartingPosition>97</ReferenceStartingPosition>
                <ReferenceEndingPosition>115</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 97-115 sequence corresponds to amino acids 113-131 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005099</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 97-128</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CYPYDVPDYASLRSLVASSGTLEFINEDFNWT</LinearSequence>
                                        <StartingPosition>113</StartingPosition>
                                        <EndingPosition>144</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/93). Two donors were screened for reactivity against the HA 97-115 region by pooling two overlapping peptides (HA 97-112 and HA 100-115). The proliferative response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 290-305</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NDKPFQNVNRITYGAC</LinearSequence>
                        <StartingPosition>306</StartingPosition>
                        <EndingPosition>321</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>43473</EpitopeId>
                <ReferenceStartingPosition>290</ReferenceStartingPosition>
                <ReferenceEndingPosition>305</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 290-305 sequence corresponds to amino acids 306-321 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005101</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 290-305</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NDKPFQNVNRITYGAC</LinearSequence>
                                        <StartingPosition>306</StartingPosition>
                                        <EndingPosition>321</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/92). Two donors were screened for reactivity against the HA 290-305 peptide. The proliferative response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 303-323</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GACPRYVKQNTLKLATGMRNV</LinearSequence>
                        <StartingPosition>319</StartingPosition>
                        <EndingPosition>339</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAT64805.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380950</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>18546</EpitopeId>
                <ReferenceStartingPosition>303</ReferenceStartingPosition>
                <ReferenceEndingPosition>323</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The HA 303-323 sequence corresponds to amino acids 319-339 of Genbank ID 49339231 for HA of Influenza A virus (A/Beijing/32/92).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005212</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAT64805.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>380950</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 303-323</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GACPRYVKQNTLKLATGMRNV</LinearSequence>
                                        <StartingPosition>319</StartingPosition>
                                        <EndingPosition>339</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAT64805.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380950</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/93). Two donors were screened for reactivity against the HA 303-323 region by pooling two overlapping peptides (HA 303-318 and HA 308-323). The proliferative response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 403-422</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GRIQDLEKYVEDTKIDLWS</LinearSequence>
                        <StartingPosition>404</StartingPosition>
                        <EndingPosition>422</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>22098</EpitopeId>
                <ReferenceStartingPosition>403</ReferenceStartingPosition>
                <ReferenceEndingPosition>422</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005217</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 403-422</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GRIQDLEKYVEDTKIDLWS</LinearSequence>
                                        <StartingPosition>404</StartingPosition>
                                        <EndingPosition>422</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/93). Two donors were screened for reactivity against the HA 403-422 region by pooling two overlapping peptides (HA 403-418 and HA 407-422). The proliferative response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 417-437</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KIDLWSYNAELLVALENQHTI</LinearSequence>
                        <StartingPosition>417</StartingPosition>
                        <EndingPosition>437</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10001157</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>31201</EpitopeId>
                <ReferenceStartingPosition>417</ReferenceStartingPosition>
                <ReferenceEndingPosition>437</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Peptide sequence is for the HA protein of Influenza A/Hong Kong/90, but no Swiss-Prot ID is available for the HA protein of this influenza strain. Swiss Prot ID P12589 is for Influenza A/Memphis/6/86 (H3N2) and is identical to the Influenza A/Hong Kong/90 sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1005224</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P12589.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10001157</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Twelve donors had a history of recent (3-6 months) flu infection, and the other 6 had no history of influenza-like illness during the previous 4 years. However, natural infection at some point was assumed for all donors.  PBMC were collected from donors and cultured in vitro with HA protein from Influenza A virus (A/Beijing/32/92). T cell lines maintained for longer than 7 days were restimulated every 7 days with fresh PBMC and HA protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA 417-437</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KIDLWSYNAELLVALENQHTI</LinearSequence>
                                        <StartingPosition>417</StartingPosition>
                                        <EndingPosition>437</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001157</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Human CD4+ T cell lines from recently infected (within the prior 3-6 months) donors were generated against the hemagglutinin protein (HA) of influenza A virus (A/Beijing/32/93). Two donors were screened for reactivity against the HA 417-437 region by pooling two overlapping peptides (HA 417-432 and HA 422-437). The proliferative response in both donors was shown to be HLA-DR-restricted by using anti-DR antibodies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

